Trials / Conditions / Stage II Lung Non-Small Cell Cancer AJCC v7
Stage II Lung Non-Small Cell Cancer AJCC v7
5 registered clinical trials studyying Stage II Lung Non-Small Cell Cancer AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-II NCT03158129 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (A NCT02595944 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small NCT02452463 | Roswell Park Cancer Institute | Phase 2 |
| Active Not Recruiting | Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Compl NCT02193282 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be R NCT02194738 | National Cancer Institute (NCI) | N/A |